Cargando…
Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer
Background: SARS-CoV-2 mortality rates are significantly higher in patients with lung cancer compared with the general population. However, little is known on their immunization status after vaccination. Methods: To evaluate the humoral response (seroconversion) of patients with lung cancer followin...
Autores principales: | Trontzas, Ioannis P., Vathiotis, Ioannis, Economidou, Christina, Petridou, Ioulia, Gomatou, Georgia, Grammoustianou, Maria, Tsamis, Ioannis, Syrigos, Nikolaos, Anagnostakis, Maximilian, Fyta, Eleni, Sakka, Vissaria, Poulakou, Garyphalia, Kotteas, Elias A., Syrigou, Ekaterini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031406/ https://www.ncbi.nlm.nih.gov/pubmed/35455367 http://dx.doi.org/10.3390/vaccines10040618 |
Ejemplares similares
-
189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer
por: Trontzas, I.P., et al.
Publicado: (2022) -
Significant Increase in Blood Pressure Following BNT162b2 mRNA COVID-19 Vaccination among Healthcare Workers: A Rare Event
por: Syrigos, Nikolaos, et al.
Publicado: (2022) -
Tumor Dormancy: Implications for Invasion and Metastasis
por: Gomatou, Georgia, et al.
Publicado: (2021) -
Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence?
por: Trontzas, Ioannis P., et al.
Publicado: (2022) -
Emerging therapies in thymic epithelial tumors (Review)
por: Dapergola, Athina, et al.
Publicado: (2023)